Key facts
- This page summarizes Richard Klausner's Form 4 filing for Lyell Immunopharma, Inc. (LYEL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Jun 2024, 16:15.
Richard Klausner - 14 Jun 2024 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)
- Reporting relationship
- Director
- Issuer ticker
- LYEL
- Reported as of
- 14 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2024, 16:15:57 UTC
- Prior SEC filing
- 08 Sep 2023
- Next SEC filing
- 18 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Lang, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard Klausner filed Form 4 for Lyell Immunopharma, Inc. (LYEL) on 17 Jun 2024.
Change
- Previous filing in this sequence was filed on 08 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LYEL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,967,834
- Date
- 14 Jun 2024
- Ownership
- Direct
LYEL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 685,365
- Date
- 14 Jun 2024
- Ownership
- Grantor
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LYEL
transaction
Derivative
Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +130,000
- Change %
- Price
- $0.000000
- Shares after
- 130,000
- Date
- 14 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 130,000
- Exercise price
- $2.36
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of 245,515 shares held by The Ariella Klausner Delaware Trust, 194,335 shares held by The Eli Klausner Delaware Trust and 245,515 shares held by The Olivia Klausner Delaware Trust. The Reporting Person is a grantor of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein. The JTC Trust Company (Delaware) Limited is the trustee of each of the trusts.
Footnote F2
The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 14, 2024 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 14, 2024, subject to the Reporting Person providing continuous service through such date.